1233
3407
$190,777,299,255
$1,084,152,303
68%

Omar Zaki

CTO at MBYS

Omar also serves as the CEO and Chief Portfolio Manager of Armitage Capital, a hedge fund focused on investing in biotechnology companies. Prior to this, he was a software developer at several large hedge funds focused on biotechnology investing, as well as Morgan Stanley’s Institutional Equities Division. He is also a biologist researching the Golgi under the advisory James Rothman, attempting to elucidate the structural mechanisms behind intra-Golgi protein trafficking. He was an early investor in the crypto space and continues to remain passionate about the space. He studied Computer Science, Physics and Economics at Yale University.

Cookie Policy

Cryptobrowser.io uses cookies to enhance your experience. By continuing without changing your settings, you agree to this use. To provide the best blockchain and crypto media on the web for free, we also request your permission for our partners and us to use cookies to personalize ads. To allow this, please click "OK". Need more info? Take a look at our Cookie Policy.

OK Cookie Policy